• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Group Vice President Rakow Joseph sold $122,254 worth of shares (1,573 units at $77.72), closing all direct ownership in the company (SEC Form 4)

    5/27/25 8:27:44 PM ET
    $EXPO
    Professional Services
    Consumer Discretionary
    Get the next $EXPO alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Rakow Joseph

    (Last) (First) (Middle)
    149 COMMONWEALTH DRIVE

    (Street)
    MENLO PARK CA 94025

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    EXPONENT INC [ EXPO ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Group Vice President
    3. Date of Earliest Transaction (Month/Day/Year)
    05/27/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/27/2025 S 1,573 D $77.7204 0 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    By: Wendy Whitehouse For: Joseph Rakow 05/27/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $EXPO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EXPO

    DatePrice TargetRatingAnalyst
    6/1/2023$99.00Neutral
    UBS
    More analyst ratings

    $EXPO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Exponent Reports First Quarter 2025 Financial Results

      MENLO PARK, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ:EXPO) today reported financial results for the first quarter of fiscal year 2025 ended April 4, 2025. "Exponent's first quarter results exceeded expectations, reinforcing both the resilience of our diversified business model and the value we deliver," said Dr. Catherine Corrigan, President and Chief Executive Officer. "Our failure analysis expertise drove increased dispute-related activities in the chemicals, transportation and utilities industries. Proactive engagements were led by risk management and regulatory support activities. As expected, we were impacted by easing in the consumer electronics industry due

      5/1/25 4:05:00 PM ET
      $EXPO
      Professional Services
      Consumer Discretionary
    • Exponent Declares Regular Quarterly Dividend for Q2 2025

      MENLO PARK, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be paid on June 20, 2025 to all common stockholders of record as of June 6, 2025. Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent's Board of Directors. "Exponent's quarterly cash dividend demonstrates our unwavering commitment to delivering value for our shareholders,

      5/1/25 4:05:00 PM ET
      $EXPO
      Professional Services
      Consumer Discretionary
    • Exponent to Announce First Quarter of Fiscal Year 2025 Results and Host Quarterly Conference Call on May 1, 2025

      MENLO PARK, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ:EXPO), today announced that it will report First Quarter of fiscal year 2025 financial results for the period ended April 4, 2025 following the close of the market on Thursday, May 1, 2025. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results. Event: Exponent, Inc. First Quarter of Fiscal Year 2025 Financial Results Conference CallDate: Thursday, May 1, 2025Time: 4:30 p.m. Eastern Time / 1:

      4/10/25 4:05:00 PM ET
      $EXPO
      Professional Services
      Consumer Discretionary

    $EXPO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Exponent Inc.

      SC 13G/A - EXPONENT INC (0000851520) (Subject)

      10/3/24 5:02:03 PM ET
      $EXPO
      Professional Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Exponent Inc. (Amendment)

      SC 13G/A - EXPONENT INC (0000851520) (Subject)

      4/10/24 2:03:52 PM ET
      $EXPO
      Professional Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Exponent Inc. (Amendment)

      SC 13G/A - EXPONENT INC (0000851520) (Subject)

      2/13/24 5:04:33 PM ET
      $EXPO
      Professional Services
      Consumer Discretionary

    $EXPO
    Financials

    Live finance-specific insights

    See more
    • Exponent Reports First Quarter 2025 Financial Results

      MENLO PARK, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ:EXPO) today reported financial results for the first quarter of fiscal year 2025 ended April 4, 2025. "Exponent's first quarter results exceeded expectations, reinforcing both the resilience of our diversified business model and the value we deliver," said Dr. Catherine Corrigan, President and Chief Executive Officer. "Our failure analysis expertise drove increased dispute-related activities in the chemicals, transportation and utilities industries. Proactive engagements were led by risk management and regulatory support activities. As expected, we were impacted by easing in the consumer electronics industry due

      5/1/25 4:05:00 PM ET
      $EXPO
      Professional Services
      Consumer Discretionary
    • Exponent Declares Regular Quarterly Dividend for Q2 2025

      MENLO PARK, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be paid on June 20, 2025 to all common stockholders of record as of June 6, 2025. Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent's Board of Directors. "Exponent's quarterly cash dividend demonstrates our unwavering commitment to delivering value for our shareholders,

      5/1/25 4:05:00 PM ET
      $EXPO
      Professional Services
      Consumer Discretionary
    • Exponent to Announce First Quarter of Fiscal Year 2025 Results and Host Quarterly Conference Call on May 1, 2025

      MENLO PARK, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ:EXPO), today announced that it will report First Quarter of fiscal year 2025 financial results for the period ended April 4, 2025 following the close of the market on Thursday, May 1, 2025. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results. Event: Exponent, Inc. First Quarter of Fiscal Year 2025 Financial Results Conference CallDate: Thursday, May 1, 2025Time: 4:30 p.m. Eastern Time / 1:

      4/10/25 4:05:00 PM ET
      $EXPO
      Professional Services
      Consumer Discretionary

    $EXPO
    SEC Filings

    See more
    • SEC Form 10-Q filed by Exponent Inc.

      10-Q - EXPONENT INC (0000851520) (Filer)

      5/9/25 4:03:51 PM ET
      $EXPO
      Professional Services
      Consumer Discretionary
    • Exponent Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - EXPONENT INC (0000851520) (Filer)

      5/1/25 4:05:21 PM ET
      $EXPO
      Professional Services
      Consumer Discretionary
    • SEC Form DEF 14A filed by Exponent Inc.

      DEF 14A - EXPONENT INC (0000851520) (Filer)

      4/21/25 4:30:35 PM ET
      $EXPO
      Professional Services
      Consumer Discretionary

    $EXPO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • UBS initiated coverage on Exponent with a new price target

      UBS initiated coverage of Exponent with a rating of Neutral and set a new price target of $99.00

      6/1/23 7:40:10 AM ET
      $EXPO
      Professional Services
      Consumer Discretionary

    $EXPO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Group Vice President Rakow Joseph sold $122,254 worth of shares (1,573 units at $77.72), closing all direct ownership in the company (SEC Form 4)

      4 - EXPONENT INC (0000851520) (Issuer)

      5/27/25 8:27:44 PM ET
      $EXPO
      Professional Services
      Consumer Discretionary
    • Group Vice President Pye John sold $152,639 worth of shares (2,000 units at $76.32), decreasing direct ownership by 6% to 29,204 units (SEC Form 4)

      4 - EXPONENT INC (0000851520) (Issuer)

      5/23/25 4:59:34 PM ET
      $EXPO
      Professional Services
      Consumer Discretionary
    • Group Vice President James Bradley A sold $214,233 worth of shares (2,694 units at $79.52), closing all direct ownership in the company (SEC Form 4)

      4 - EXPONENT INC (0000851520) (Issuer)

      5/21/25 5:04:33 PM ET
      $EXPO
      Professional Services
      Consumer Discretionary